AXSOME THERAPEUTICS, INC. Investment Income, Net
AXSOME THERAPEUTICS, INC. (AXSM) reported Investment Income, Net of -$1.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. investment income, net for the quarter ending 2026-06-30 was -$1.54M.
- AXSOME THERAPEUTICS, INC. investment income, net for the quarter ending 2026-03-31 was -$1.19M.
- AXSOME THERAPEUTICS, INC. investment income, net for the quarter ending 2025-12-31 was -$1.17M.
- AXSOME THERAPEUTICS, INC. investment income, net for the quarter ending 2025-09-30 was -$1.12M.
- AXSOME THERAPEUTICS, INC. investment income, net for fiscal 2025 was -$6.56M.
- AXSOME THERAPEUTICS, INC. investment income, net for fiscal 2024 was -$6.57M.
- AXSOME THERAPEUTICS, INC. investment income, net for fiscal 2023 was -$6.45M.
- AXSOME THERAPEUTICS, INC. investment income, net for fiscal 2022 was -$7.33M.
| Period end | Investment Income, Net 3 month | Investment Income, Net 3 month as first filed | Investment Income, Net 6 month | Investment Income, Net 6 month as first filed | Investment Income, Net 9 month | Investment Income, Net 9 month as first filed | Investment Income, Net 12 month | Investment Income, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.54M 10-Q · filed 2026-08-10 | -$2.73M 10-Q · filed 2026-08-10 | -$3.90M derived: sum of 3 quarters · filed 2026-08-10 | -$5.02M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$1.19M 10-Q · filed 2026-05-04 | -$2.36M derived: sum of 2 quarters · filed 2026-05-04 | -$3.48M derived: sum of 3 quarters · filed 2026-05-04 | -$5.31M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$2.29M derived: sum of 2 quarters · filed 2026-02-23 | -$4.13M derived: sum of 3 quarters · filed 2026-08-10 | -$6.56M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | -$1.12M 10-Q · filed 2025-11-03 | -$2.95M derived: sum of 2 quarters · filed 2026-08-10 | -$5.38M 10-Q · filed 2025-11-03 | -$7.59M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$1.83M 10-Q · filed 2026-08-10 | -$4.26M 10-Q · filed 2026-08-10 | -$6.47M derived: sum of 3 quarters · filed 2026-08-10 | -$8.45M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$2.43M 10-Q · filed 2026-05-04 | -$4.64M derived: sum of 2 quarters · filed 2026-05-04 | -$6.62M derived: sum of 3 quarters · filed 2026-05-04 | -$7.92M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$4.19M derived: sum of 2 quarters · filed 2026-02-23 | -$5.49M derived: sum of 3 quarters · filed 2026-02-23 | -$6.57M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | -$1.98M 10-Q · filed 2025-11-03 | -$3.28M derived: sum of 2 quarters · filed 2025-11-03 | -$4.36M 10-Q · filed 2025-11-03 | -$5.06M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | -$1.30M 10-Q · filed 2025-08-04 | -$2.38M 10-Q · filed 2025-08-04 | -$3.08M derived: sum of 3 quarters · filed 2026-02-23 | -$3.84M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | -$1.08M 10-Q · filed 2025-05-05 | -$1.78M derived: sum of 2 quarters · filed 2026-02-23 | -$2.54M derived: sum of 3 quarters · filed 2026-02-23 | -$5.27M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.46M derived: sum of 2 quarters · filed 2026-02-23 | -$4.19M derived: sum of 3 quarters · filed 2026-02-23 | -$6.45M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | -$757.00K 10-Q · filed 2024-11-12 | -$3.49M derived: sum of 2 quarters · filed 2024-11-12 | -$5.75M 10-Q · filed 2024-11-12 | -$7.07M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | -$2.73M 10-Q · filed 2024-08-05 | -$4.99M 10-Q · filed 2024-08-05 | -$6.32M derived: sum of 3 quarters · filed 2025-02-18 | -$8.73M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | -$2.26M 10-Q · filed 2024-05-06 | -$3.59M derived: sum of 2 quarters · filed 2025-02-18 | -$6.00M derived: sum of 3 quarters · filed 2025-02-18 | -$8.26M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$3.73M derived: sum of 2 quarters · filed 2025-02-18 | -$5.99M derived: sum of 3 quarters · filed 2025-02-18 | -$7.33M 10-K · filed 2025-02-18 | -$7.33M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$2.41M 10-Q · filed 2023-11-06 | -$2.41M 10-Q · filed 2022-11-07 | -$4.67M derived: sum of 2 quarters · filed 2023-11-06 | -$6.01M 10-Q · filed 2023-11-06 | -$6.01M 10-Q · filed 2022-11-07 | -$7.38M derived: sum of 4 quarters · filed 2024-02-23 | ||
| 2022-06-30 | -$2.26M 10-Q · filed 2023-08-07 | -$2.26M 10-Q · filed 2022-08-09 | -$3.60M 10-Q · filed 2023-08-07 | -$3.60M 10-Q · filed 2022-08-09 | -$4.97M derived: sum of 3 quarters · filed 2024-02-23 | -$6.44M derived: sum of 4 quarters · filed 2024-02-23 | ||
| 2022-03-31 | -$1.34M 10-Q · filed 2023-05-09 | -$1.34M 10-Q · filed 2022-05-02 | -$2.71M derived: sum of 2 quarters · filed 2024-02-23 | -$4.19M derived: sum of 3 quarters · filed 2024-02-23 | -$5.62M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$2.84M derived: sum of 2 quarters · filed 2024-02-23 | -$4.28M derived: sum of 3 quarters · filed 2024-02-23 | -$5.70M 10-K · filed 2024-02-23 | -$5.70M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$1.48M 10-Q · filed 2022-11-07 | -$2.91M derived: sum of 2 quarters · filed 2022-11-07 | -$4.33M 10-Q · filed 2022-11-07 | -$5.80M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$1.44M 10-Q · filed 2022-08-09 | -$2.85M 10-Q · filed 2022-08-09 | -$4.33M derived: sum of 3 quarters · filed 2023-02-28 | -$4.88M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$1.42M 10-Q · filed 2022-05-02 | -$2.89M derived: sum of 2 quarters · filed 2023-02-28 | -$3.44M derived: sum of 3 quarters · filed 2023-02-28 | -$3.99M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.02M derived: sum of 2 quarters · filed 2023-02-28 | -$2.57M derived: sum of 3 quarters · filed 2023-02-28 | -$2.57M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$551.00K 10-Q · filed 2021-11-08 | -$1.10M derived: sum of 2 quarters · filed 2021-11-08 | -$1.09M 10-Q · filed 2021-11-08 | -$1.47M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$548.16K 10-Q · filed 2021-08-09 | -$540.85K 10-Q · filed 2021-08-09 | -$919.66K derived: sum of 3 quarters · filed 2022-03-01 | -$1.25M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $7.31K 10-Q · filed 2021-05-10 | -$371.50K derived: sum of 2 quarters · filed 2022-03-01 | -$699.33K derived: sum of 3 quarters · filed 2022-03-01 | -$1.01M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$378.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$706.64K derived: sum of 2 quarters · filed 2022-03-01 | -$1.02M derived: sum of 3 quarters · filed 2022-03-01 | -$1.24M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$327.82K 10-Q · filed 2020-11-05 | -$641.82K derived: sum of 2 quarters · filed 2020-11-05 | -$860.72K 10-Q · filed 2020-11-05 | -$1.11M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$314.00K 10-Q · filed 2020-08-10 | -$532.90K 10-Q · filed 2020-08-10 | -$781.60K derived: sum of 3 quarters · filed 2021-03-01 | -$1.05M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$218.90K 10-Q · filed 2020-05-11 | -$467.60K derived: sum of 2 quarters · filed 2021-03-01 | -$738.54K derived: sum of 3 quarters · filed 2021-03-01 | -$1.03M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$248.70K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$519.63K derived: sum of 2 quarters · filed 2021-03-01 | -$811.96K derived: sum of 3 quarters · filed 2021-03-01 | -$1.13M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$270.93K 10-Q · filed 2019-11-07 | -$563.26K derived: sum of 2 quarters · filed 2019-11-07 | -$878.61K 10-Q · filed 2019-11-07 | -$1.22M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$292.32K 10-Q · filed 2019-08-08 | -$607.67K 10-Q · filed 2019-08-08 | -$948.05K derived: sum of 3 quarters · filed 2020-03-12 | -$1.29M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$315.35K 10-Q · filed 2019-05-09 | -$655.73K derived: sum of 2 quarters · filed 2020-03-12 | -$998.96K derived: sum of 3 quarters · filed 2020-03-12 | -$1.33M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$340.38K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$683.62K derived: sum of 2 quarters · filed 2020-03-12 | -$1.02M derived: sum of 3 quarters · filed 2020-03-12 | -$1.34M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$343.23K 10-Q · filed 2018-11-09 | -$676.81K derived: sum of 2 quarters · filed 2018-11-09 | -$999.82K 10-Q · filed 2018-11-09 | -$1.18M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | -$333.58K 10-Q · filed 2018-08-08 | -$656.58K 10-Q · filed 2018-08-08 | -$834.24K derived: sum of 3 quarters · filed 2019-03-15 | -$821.02K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | -$323.01K 10-Q · filed 2018-05-08 | -$500.66K derived: sum of 2 quarters · filed 2019-03-15 | -$487.44K derived: sum of 3 quarters · filed 2019-03-15 | -$472.35K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | -$177.66K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$164.44K derived: sum of 2 quarters · filed 2019-03-15 | -$149.35K derived: sum of 3 quarters · filed 2019-03-15 | -$132.42K 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | $13.22K 10-Q · filed 2017-11-08 | $28.31K derived: sum of 2 quarters · filed 2017-11-08 | $45.23K 10-Q · filed 2017-11-08 | -$71.17K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $15.09K 10-Q · filed 2017-08-09 | $32.01K 10-Q · filed 2017-08-09 | -$84.39K derived: sum of 3 quarters · filed 2018-03-07 | -$364.19K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $16.92K 10-Q · filed 2017-05-09 | -$99.48K derived: sum of 2 quarters · filed 2018-03-07 | -$379.28K derived: sum of 3 quarters · filed 2018-03-07 | -$590.34K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | -$116.40K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$396.20K derived: sum of 2 quarters · filed 2018-03-07 | -$607.27K derived: sum of 3 quarters · filed 2018-03-07 | -$736.05K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | -$279.80K 10-Q · filed 2016-11-14 | -$490.86K derived: sum of 2 quarters · filed 2016-11-14 | -$619.64K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$211.06K 10-Q · filed 2016-08-09 | -$339.84K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$128.78K 10-Q/A · filed 2016-08-09 | |||||||
| 2014-12-31 | $2.23M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |